AMGNAmgen Inc.

HealthcareUpdated 2026-03-13

$366.21-0.43%

Open

$370.68

High

$372.98

Low

$365.93

Volume

1.5M

Market Cap

$197.20B

P/E Ratio

25.57

P/B Ratio

22.78

Enterprise Value

$242.67B

Get AI-Powered Analysis of AMGN

Neliva uses real-time data and AI to provide deep research on Amgen Inc. — including fundamentals, risk assessment, earnings review, and actionable insights.

Research AMGN with AI Deep Analysis

Free to try — no account required for your first research.

About Amgen Inc. (AMGN)

Amgen Inc. (AMGN) is a publicly traded company in the Healthcare sector, listed as a component of the S&P 500 index. With a market capitalization of $197.20B, it is one of the significant players in its industry. The stock currently trades at a price-to-earnings ratio of 25.57.

Investors and analysts track AMGN for its performance within the Healthcare sector. Using Neliva's AI-powered research tools, you can get comprehensive analysis including real-time pricing, fundamental analysis, technical indicators, news sentiment, and risk assessment — all in seconds.

Frequently Asked Questions

What is the current price of AMGN?

As of 2026-03-13, AMGN is trading at $366.21 (-0.43% today). Range: $365.93 — $372.98.

What is the P/E ratio of AMGN?

AMGN has a P/E ratio of 25.57, helping assess valuation relative to earnings.

Is AMGN a good stock to buy?

Whether AMGN is a good investment depends on your goals and risk tolerance. Neliva’s AI provides comprehensive analysis including valuation, growth, risk factors, and analyst consensus.

What sector is AMGN in?

Amgen Inc. (AMGN) is in the Healthcare sector of the S&P 500.

Related Healthcare Stocks

LLYEli Lilly and Company UNHUnitedHealth Group Inc.JNJJohnson & Johnson ABBVAbbVie Inc.MRKMerck & Co. Inc.TMOThermo Fisher Scientific Inc.ABTAbbott Laboratories ISRGIntuitive Surgical Inc.

Research any stock with AI

Get real-time data, fundamental analysis, risk assessment, and actionable insights — powered by AI.

Get started free